Validation of new medication use algorithms as proxies for worsening disease activity in patients with juvenile idiopathic arthritis.

An algorithm for new JIA medication use appears to be a reasonable proxy for worsening JIA disease activity, particularly when specifying new use ≥1 year since initiating a prior JIA medication. This algorithm will be valuable for conducting research on JIA populations within administrative claims databases.